EMA committee endorses Takeda dengue vaccine candidate 17-Oct-2022 By Jane Byrne Takeda’s dengue vaccine candidate has been recommended for approval by an EMA commitee.
Emergex starts up production for universal influenza vaccine 01-Aug-2022 By Ben Hargreaves The UK company plans to manufacture sufficient levels of its universal influenza vaccine for use in Phase I human trials.
Emergex develops synthetic hand-foot-and-mouth vaccine 10-Jul-2019 By Vassia Barba In collaboration with a research center, Emergex will apply its synthetic development approach on a vaccine against hand, foot and mouth disease.
